Literature DB >> 8592331

Exclusion of a primary gene defect at the HLA locus in familial idiopathic dilated cardiomyopathy.

T M Olson1, S N Thibodeau, P A Lundquist, D J Schaid, V V Michels.   

Abstract

Case control studies have reported associations between specific HLA class II antigens and idiopathic dilated cardiomyopathy (DCM), suggesting that genetically regulated immune response factors may be involved in the pathogenesis of this disease. In this study, families with DCM were used to test the hypothesis that a heritable gene defect in the HLA region is the primary genetic determinant for a subset of cases. Twelve families with DCM were identified. By formal segregation analysis, the inheritance of the disease was most consistent with an autosomal dominant gene defect with incomplete penetrance. Genotyping was performed with five highly polymorphic linked dinucleotide repeat markers that span the HLA locus. Linkage analysis was used to determine whether or not these genetic markers cosegregated with the disease phenotype. Genetic linkage between the disease phenotype and a 21 cM region spanning the HLA was excluded (lod score < or = -2) in at least 60% of our families. These results indicate that a gene defect in the HLA locus region is not the primary genetic determinant of DCM in a series of familial cases. However, our data do not exclude the possibility that HLA regulated immune response factors may have a modifying effect on disease penetrance and expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8592331      PMCID: PMC1051739          DOI: 10.1136/jmg.32.11.876

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  18 in total

1.  Dinucleotide repeat polymorphism at the D6S105 locus.

Authors:  J L Weber; A E Kwitek; P E May; H Y Zoghbi
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

Review 2.  Update of the human major histocompatibility complex.

Authors:  E J Yunis; I Yunis
Journal:  Transplant Proc       Date:  1991-04       Impact factor: 1.066

3.  HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies.

Authors:  J F Carlquist; R L Menlove; M B Murray; J B O'Connell; J L Anderson
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

4.  Idiopathic dilated cardiomyopathy. An immunologic, genetic, or infectious disease, or all of the above?

Authors:  J R Bender
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

5.  Myocarditis and dilated cardiomyopathy: different stages of the same disease?

Authors:  J T Fallon
Journal:  Cardiovasc Clin       Date:  1988

6.  The EBV-hybridoma technique.

Authors:  J C Roder; S P Cole; D Kozbor
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

7.  Familial dilated cardiomyopathy and human leucocyte antigen. A report of two family cases.

Authors:  S Koike; S Kawa; K Yabu; R Endo; Y Sasaki; S Furuta; M Ota
Journal:  Jpn Heart J       Date:  1987-11

8.  Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.

Authors:  J L Weber; P E May
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

9.  Recombination rates across the HLA complex: use of microsatellites as a rapid screen for recombinant chromosomes.

Authors:  M Martin; D Mann; M Carrington
Journal:  Hum Mol Genet       Date:  1995-03       Impact factor: 6.150

10.  Linkage analysis and family classification under heterogeneity.

Authors:  J Ott
Journal:  Ann Hum Genet       Date:  1983-10       Impact factor: 1.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.